These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26762226)

  • 1. Transgender Patients, Isotretinoin, and US Food and Drug Administration-Mandated Risk Evaluation and Mitigation Strategies: A Prescription for Inclusion.
    Katz KA
    JAMA Dermatol; 2016 May; 152(5):513-4. PubMed ID: 26762226
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethical and legal aspects of teratogenic medications: the case of isotretinoin.
    Moskop JC; Smith ML; De Ville K
    J Clin Ethics; 1997; 8(3):264-78. PubMed ID: 9436085
    [No Abstract]   [Full Text] [Related]  

  • 3. Isotretinoin prescribing: finding a balance between benefit and risk.
    Stern RS
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):611-3. PubMed ID: 16134100
    [No Abstract]   [Full Text] [Related]  

  • 4. Prescribing isotretinoin in the United States for transgender individuals: Ethical considerations.
    Yeung H; Chen SC; Katz KA; Stoff BK
    J Am Acad Dermatol; 2016 Sep; 75(3):648-651. PubMed ID: 27543225
    [No Abstract]   [Full Text] [Related]  

  • 5. US FDA Advisory Committee meetings held to discuss isotretinoin, safety issues and a new accutane formulation.
    Maddin S
    Skin Therapy Lett; 2000; 6(2):5. PubMed ID: 11071724
    [No Abstract]   [Full Text] [Related]  

  • 6. Isotretinoin made S.M.A.R.T. and simple.
    Lowenstein EJ
    Cutis; 2002 Aug; 70(2):115-20. PubMed ID: 12234158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA, Roche to implement new dispensing procedures for isotretinoin.
    Young D
    Am J Health Syst Pharm; 2001 Dec; 58(24):2359-60. PubMed ID: 11794946
    [No Abstract]   [Full Text] [Related]  

  • 8. Accutane (isotretinoin) and psychiatric adverse effects.
    Wooltorton E
    CMAJ; 2003 Jan; 168(1):66. PubMed ID: 12515789
    [No Abstract]   [Full Text] [Related]  

  • 9. The cost of clear skin: balancing the social and safety costs of iPLEDGE with the efficacy of Accutane (isotretinoin).
    Doshi A
    Seton Hall Law Rev; 2007; 37(2):625-60. PubMed ID: 17294569
    [No Abstract]   [Full Text] [Related]  

  • 10. The Food and Drug Administration Should Mandate Risk Evaluation and Mitigation Strategies Training for All Opioids.
    Soelberg CD; Chou R; Ramachandran BK; Berkeley A; Brown RE
    Anesth Analg; 2018 Apr; 126(4):1413-1417. PubMed ID: 29547432
    [No Abstract]   [Full Text] [Related]  

  • 11. A Call for Gender Identity Data Collection in iPLEDGE and Increasing the Number of Isotretinoin Prescribers Among Transgender Health Providers.
    Singer S; Keuroghlian AS
    LGBT Health; 2020 Jul; 7(5):216-219. PubMed ID: 32456537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing isotretinoin for transgender youth: A pledge for more inclusive care.
    Boos MD; Ginsberg BA; Peebles JK
    Pediatr Dermatol; 2019 Jan; 36(1):169-171. PubMed ID: 30318854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Federal Right-to-Try Legislation - Threatening the FDA's Public Health Mission.
    Joffe S; Lynch HF
    N Engl J Med; 2018 Feb; 378(8):695-697. PubMed ID: 29320302
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris.
    Layton AM; Dreno B; Gollnick HP; Zouboulis CC
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):773-6. PubMed ID: 16898895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isotretinoin systemic therapy and the shadow cast upon dermatology's downtrodden hero.
    Lowenstein EB; Lowenstein EJ
    Clin Dermatol; 2011; 29(6):652-61. PubMed ID: 22014987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating Acne in Transgender Persons Receiving Testosterone: A Practical Guide.
    Radi R; Gold S; Acosta JP; Barron J; Yeung H
    Am J Clin Dermatol; 2022 Mar; 23(2):219-229. PubMed ID: 35018581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management.
    Del Rosso JQ
    J Drugs Dermatol; 2013 Jun; 12(6):626-31. PubMed ID: 23839177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roche responds to 'new warnings on the use of isotretinoin (Roaccutane)'.
    Ebrahim O; Bredenhann M
    S Afr Med J; 1999 Jan; 89(1):16. PubMed ID: 10070397
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe Acne in Female-to-Male Transgender Patients.
    Turrion-Merino L; Urech-García-de-la-Vega M; Miguel-Gomez L; Harto-Castaño A; Jaen-Olasolo P
    JAMA Dermatol; 2015 Nov; 151(11):1260-1. PubMed ID: 25992965
    [No Abstract]   [Full Text] [Related]  

  • 20. Usage and equity of access to isotretinoin in New Zealand by deprivation and ethnicity.
    Moodie P; Jaine R; Arnold J; Bignall M; Metcalfe S; Arroll B
    N Z Med J; 2011 Nov; 124(1346):34-43. PubMed ID: 22143851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.